U.S. FDA approves TB Alliance's treatment for drug|resistant ...

FDA approves new drug for treatment-resistant forms of tuberculosis ...

The US Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of ...

FDA Approves New Treatment for Highly Drug-Resistant Forms of ...

NEW YORK (August 14, 2019)—Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S..

A new treatment - Annual Report 2019 | TB Alliance

A New Treatment Full Prescribing Information U.S. FDA Approves New Treatment for Highly Drug-Resistant TB On August 14, 2019, TB Alliance ...

U.S. Food and Drug Administration (FDA) Approves Pretomanid

On August 14, 2019 the FDA granted approval for Pretomanid Tablets to the nonprofit. Global Alliance for TB Drug Development (TB Alliance).

Union welcomes FDA approval of TB Alliance's BPaL treatment for ...

The Union welcomes today's announcement that a new treatment developed by the TB Alliance has been approved by the U.S. Food and Drug ...

U.S. FDA approves TB Alliance's treatment for drug-resistant ...

The U.S. Food and Drug Administration has approved TB Alliance's treatment for drug-resistant tuberculosis as part of a three-drug ...

FDA approves another drug for drug-resistant TB but questions ...

*Update, 15 August, noon: The U.S. Food and Drug Administration (FDA) yesterday approved a new drug, pretomanid, to treat highly ...

FDA approves breakthrough drug to treat Extensively Drug ...

TB Alliance is a nonprofit product development partnership that RTI and Rouse helped to form in 2000, which has now negotiated license ...

FDA approves new drug for highly resistant tuberculosis - CIDRAP

The US Food and Drug Administration (FDA) today announced the approval of a new antibiotic for treating the most drug-resistant forms of ...

FDA approves TB pill that cures more hard-to-treat patients | STAT

It's the first TB drug from a nonprofit group. The TB Alliance, formed to come up with better treatments, developed pretomanid with help from ...

Provisional CDC Guidance for the Use of Pretomanid as part of a ...

Based largely on the results of the Nix-TB trial9, FDA approved pretomanid in the context of BPaL, i.e., to be administered as part of a ...

Treatment for extreme drug-resistant tuberculosis wins US ... - Nature

The US Food and Drug Administration has approved a drug regimen to treat an extreme form of multi-drug-resistant tuberculosis (TB).

One Year Since U.S. Approval, Accelerating Access to New TB ...

Pretomanid is an anti-TB drug which has been developed by TB Alliance, a non-profit product development partnership dedicated to improving ...

FDA approval of BPaL regimen an important breakthrough in TB ...

The US Food & Drug Administration (FDA) today approved pretomanid for the treatment of highly drug-resistant forms of tuberculosis (TB) in a combination ...

FDA Approves Drug to Treat Extensively Drug-Resistant Tuberculosis

TB Alliance acquired the license to pretomanid, then known as Pa-824, in 2002. RTI assisted TB Alliance in planning and managing the preclinical ...

Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United ...

The US Food and Drug Administration approved a 6-month regimen of pretomanid, bedaquiline, and linezolid for extensively drug-resistant or ...

FDA approves pretomanid for highly drug-resistant forms of TB

Pretomanid receives FDA approval in combination regimen with bedaquiline and linezolid for people with XDR-TB or treatment-intolerant/non- ...

FDA Advisory Panel Recommends Approval For TB Alliance's ... - KFF

“Independent experts of an FDA advisory panel voted in favor of the not-for-profit TB Alliance's treatment for drug-resistant tuberculosis, as a ...

FDA Approves New Treatment For Drug-Resistant TB; Activists Call ...

The US Food and Drug Administration (FDA) last week approved a tuberculosis (TB) treatment regimen containing a new drug, pretomanid, offering a shorter, ...

FDA Approves New Drug for Treatment-Resistant Forms of ...

The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a ...